| Title: | Geographical full time professor |
| Address: | Département de microbiologie CHUM1050, rue Sanguinet, Pavillon F bureau F-05-1044 Montréal (Québec) H2X 0C2 |
| Phone: | 514 890-8000, ext. 36210 |
| Email: | francois.coutlee@ssss.gouv.qc.ca |
Biography
To come up
Team
- Émile Comète
- Julie Guenoun
- Catherine Rodrigues-Coutlée
Theme
HPV infection in HIV infected hosts
Anogenital HPV infection and cancer: prevention, transmission and detection.
Research topics
- Non isotopic PCR assays for viral diagnosis.
- HPV and genital cancers.
- Molecular analysis of persistent HPV infection.
- HPV viral load with real time PCR
Publications
- de Pokomandy A, Kaufman E, de Castro C, Mayrand MH, Burchell A, Klein M, Charest L, Auger M, Rodrigues-Coutlée S, Coutlée F. The EVVA cohort study: anal and cervical type-specific HPV prevalence, persistence and cytology in women living with HIV. Journal of Infectious Diseases 2017;216:447-456.
- de Pokomandy A, Ghattas G, Rouleau D, Lalonde R, Beauvais C, de Castro C, Coutlée F. Argon Plasma Coagulation treatment of anal high-grade squamous intraepithelial lesions in men having sex with men living with HIV: results of a 2-year prospective pilot study. HIV Medicine 2018:10.1111/hiv.12544.
- Mayrand MH, Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, Franco EL; CCCaST Study Group. Randomized controlled trial of human papillomavirus testing versus Pap cytology for primary screening of cervical cancer precursors: results from the Canadian Cervical Cancer Screening Trial (CCCaST). Int J Cancer. 2006 Aug 1;119(3):615-23.
- Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL; Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. The New England Journal of Medicine 2007;357:1579-1588.
- Isidean SD, Mayrand MH, Ramanakumar AV, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL. Comparison of triage strategies for HPV positive women: Canadian cervical cancer screening trial results. Cancer Epidemiol Biomarkers Prev. 2017 ; 26:923-929.
- Formentin A, Archambault J, Koushik A, Richardson H, Brassard P, Franco EL, Coutlée F. Human papillomavirus type 52 polymorphism and high-grade lesions of the uterine cervix. International Journal of Cancer 2013:132, 1821–1830.